Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xia Fu

Showing results (211-220 of 281) with videos related to

Pageof 29
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2018
Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling TransplantationChen-Hua Yan, Yu Wang, Xiao-Dong Mo, et al.
Biomaterials|July 6, 2010
Rapid construction of mechanically- confined multi- cellular structures using dendrimeric intercellular linkerXuejun Mo, Qiushi Li, Lena Wai Yi Lui, et al.
Chinese Medical Journal|March 20, 2013
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survivalXiao-Hui Zhang, Xiao-Jun Huang, Kai-Yan Liu, et al.
Thrombosis Research|March 10, 2015
Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled studyXiao-Hui Zhang, Xiao-Lu Zhu, Ting Niu, et al.
Bone Marrow Transplantation|January 30, 2020
Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantationChen-Hua Yan, Yu Wang, Xiao-Dong Mo, et al.
American Journal of Translational Research|May 10, 2016
Elevated serum IL-35 and increased expression of IL-35-p35 or -EBI3 in CD4(+)CD25(+) T cells in patients with active tuberculosisBin Kong, Gan-Bin Liu, Jun-Ai Zhang, et al.
Bone Marrow Transplantation|April 13, 2021
Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantationJin Wu, Hai-Xia Fu, Yun He, et al.
Medcomm|January 19, 2026
Low Dose of IL-2 Application for Graft-Versus-Host Disease Prophylaxis Following Haploidentical Stem Cell TransplantationZheng-Li Xu, Meng Lv, Xing-Xing Yu, et al.
Annals of Hematology|January 15, 2025
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemiaJun Kong, Feng-Mei Zheng, Chen-Hua Yan, et al.
Blood Cell Therapy|June 9, 2025
PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantationLing Ma, Si-Qi Li, Wei Han, et al.
Pageof 29

Showing results (211-220 of 281) with videos related to

Sort By:
Pageof 29
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2018
Incidence, Risk Factors, Microbiology and Outcomes of Pre-engraftment Bloodstream Infection After Haploidentical Hematopoietic Stem Cell Transplantation and Comparison With HLA-identical Sibling TransplantationChen-Hua Yan, Yu Wang, Xiao-Dong Mo, et al.
Biomaterials|July 6, 2010
Rapid construction of mechanically- confined multi- cellular structures using dendrimeric intercellular linkerXuejun Mo, Qiushi Li, Lena Wai Yi Lui, et al.
Chinese Medical Journal|March 20, 2013
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survivalXiao-Hui Zhang, Xiao-Jun Huang, Kai-Yan Liu, et al.
Thrombosis Research|March 10, 2015
Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled studyXiao-Hui Zhang, Xiao-Lu Zhu, Ting Niu, et al.
Bone Marrow Transplantation|January 30, 2020
Incidence, risk factors, and outcomes of cytomegalovirus retinitis after haploidentical hematopoietic stem cell transplantationChen-Hua Yan, Yu Wang, Xiao-Dong Mo, et al.
American Journal of Translational Research|May 10, 2016
Elevated serum IL-35 and increased expression of IL-35-p35 or -EBI3 in CD4(+)CD25(+) T cells in patients with active tuberculosisBin Kong, Gan-Bin Liu, Jun-Ai Zhang, et al.
Bone Marrow Transplantation|April 13, 2021
Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantationJin Wu, Hai-Xia Fu, Yun He, et al.
Medcomm|January 19, 2026
Low Dose of IL-2 Application for Graft-Versus-Host Disease Prophylaxis Following Haploidentical Stem Cell TransplantationZheng-Li Xu, Meng Lv, Xing-Xing Yu, et al.
Annals of Hematology|January 15, 2025
Efficacy and safety of olverembatinib as maintenance therapy after allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemiaJun Kong, Feng-Mei Zheng, Chen-Hua Yan, et al.
Blood Cell Therapy|June 9, 2025
PD-1 inhibitor in patients with minimal residual disease who failed donor lymphocyte infusion or interferon after allogeneic haematopoietic stem cell transplantationLing Ma, Si-Qi Li, Wei Han, et al.
Pageof 29